|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1999-10-8
|
|
pubmed:abstractText |
Treatment of neuroblastoma has remained a major challenge in pediatric oncology because the assessment of the individual prognosis, particularly in disseminated disease is still obscure. Previous studies have correlated clinical outcome with activity levels of telomerase, a cellular reverse transcriptase which has been detected in the majority of human malignant tumors.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
715-21
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10442195-Amino Acid Sequence,
pubmed-meshheading:10442195-Child,
pubmed-meshheading:10442195-Child, Preschool,
pubmed-meshheading:10442195-Female,
pubmed-meshheading:10442195-Ganglioneuroma,
pubmed-meshheading:10442195-Gene Amplification,
pubmed-meshheading:10442195-Humans,
pubmed-meshheading:10442195-Infant,
pubmed-meshheading:10442195-Infant, Newborn,
pubmed-meshheading:10442195-Male,
pubmed-meshheading:10442195-Molecular Sequence Data,
pubmed-meshheading:10442195-Neoplasm Staging,
pubmed-meshheading:10442195-Neuroblastoma,
pubmed-meshheading:10442195-Prognosis,
pubmed-meshheading:10442195-Survival Analysis,
pubmed-meshheading:10442195-Telomerase
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Telomerase activity distinguishes between neuroblastomas with good and poor prognosis.
|
|
pubmed:affiliation |
Gerhard-Domagk-Institute of Pathology, University of Münster, Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
